Aranidipine
Antihypertensive medication
Aranidipine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | Oral |
Pregnancy category | |
Bioavailability | 20% |
Metabolism | Hepatic |
Elimination half-life | 8 hours |
Excretion | Renal |
Legal status | Rx-only |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Aranidipine is a calcium channel blocker used as an antihypertensive agent. It is primarily prescribed for the management of hypertension (high blood pressure). Aranidipine belongs to the dihydropyridine class of calcium channel blockers, which are known for their ability to selectively inhibit the influx of calcium ions into vascular smooth muscle and cardiac muscle cells, leading to vasodilation and reduced blood pressure.
Pharmacology[edit | edit source]
Aranidipine works by blocking the L-type calcium channels in the smooth muscle of the vasculature. This action prevents calcium from entering the cells, which is necessary for muscle contraction. As a result, the blood vessels relax and dilate, leading to a decrease in systemic vascular resistance and a subsequent reduction in blood pressure.
Pharmacokinetics[edit | edit source]
Aranidipine is administered orally and has a bioavailability of approximately 20%. It is highly protein-bound (95%) and undergoes extensive hepatic metabolism. The elimination half-life of aranidipine is about 8 hours, and it is primarily excreted through the renal route.
Clinical Use[edit | edit source]
Aranidipine is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents such as ACE inhibitors, angiotensin II receptor blockers, or diuretics. The choice of combination therapy depends on the individual patient's response and the presence of comorbid conditions.
Side Effects[edit | edit source]
Common side effects of aranidipine include headache, dizziness, flushing, and peripheral edema. These effects are generally mild and tend to diminish with continued use. As with other calcium channel blockers, there is a potential for reflex tachycardia due to the vasodilatory effects.
Related pages[edit | edit source]
Gallery[edit | edit source]
Aranidipine[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD